Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China

Fig. 3

Sensitivity and 1-specificity of optimized triage strategies in hrHPV-positive, cytology-negative women. CIN2+/CIN3+: cervical intraepithelial neoplasia 2/3 or worse. (A) CIN2+, n = 136; (B) CIN3+, n = 53. Bars represented 95% confidence intervals. The black trapezoid represents HPV16/18 genotyping. The favorable strategies to HPV16/18 genotyping are shown in gray

Back to article page